(Q47413484)

15 January 2018

title

Early weight loss and outcome at one year in obese adolescents treated with orlistat or placebo (English)

1 reference

15 January 2018

1 reference

Jean-Pierre Chanoine

1

0 references

author name string

Matthew Richard

series ordinal

2

1 reference

15 January 2018

publication date

22 September 2010

1 reference

15 January 2018

published in

Pediatric Obesity

1 reference

15 January 2018

volume

6

1 reference

15 January 2018

issue

2

1 reference

15 January 2018

page(s)

95-101

1 reference

15 January 2018

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

cites work

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

Rise in antiobesity drug prescribing for children and adolescents in the UK: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

Adiposity in adolescents: change in actual BMI works better than change in BMI z score for longitudinal studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

Obesity in children and young people: a crisis in public health

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

Screening and interventions for childhood overweight: a summary of evidence for the US Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

Efficacy of weight loss drugs on obesity and cardiovascular risk factors in obese adolescents: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

Efficacy and safety of anti-obesity drugs in children and adolescents: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

Four-year follow-up of children and adolescents participating in an obesity intervention program.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

Lessons from obesity management programmes: greater initial weight loss improves long-term maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

Early treatment response as a predictor of ongoing weight loss in obesity treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

Influence of a lipase inhibitor on gastric sensitivity and accommodation to an orally ingested meal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

The long-term influence of orlistat on dietary intake in obese subjects with components of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

Effect of orlistat on eating behavior among participants in a 3-year weight maintenance trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

Comparison of efficacy of sibutramine or orlistat versus their combination in obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

Efficacy of sibutramine, orlistat and combination therapy on short-term weight management in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17477166.2010.519387

10.3109/17477166.2010.519387

21 January 2018

Identifiers

DOI

1 reference

15 January 2018

PubMed ID

20858149

1 reference

15 January 2018